Serum prostate-specific antigen in pancreatic disease

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7, 1999, Pages 580-583

  Pezzilli, R ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute pancreatitis; Chronic pancreatitis; Pancreatic cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; PANCREAS DISEASE; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

EID: 0032704013     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Werner N, Albrech M, Sesterhenn I, Goebbels R, Bonkhoff H, Seitz G, et al. The "female prostate": location, morphology, immunohistochemical characteristics and significance. Eur Urol 1992;22:64-9.
2. Yu H, Diamandis EP. Prostate specific antigen in milk of lactating women. Clin Chem 1994;41:54-60.
3. Yu H, Diamandis EP. Prostate specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995;41:204-10.
4. Elgaman AAA, Ectors NL, Sunardhi-Widyaputra S, Van Poppel HP, Van Damme J, Baert LV. Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overstimation. J Urol 1996;156:464-8.
5. Levesque M, Yu H, D'Costa M, Diamandis EP. Prostate specific antigen expression by various tumours. J Clin Lab Anal 1995;9:123-8.
6. Levesque M, Yu H, D'Costa M, Tadross L, Diamandis EP. Immunoreactive prostate specific antigen in lung tumours. J Clin Lab Anal 1995;9:375-9.
7. Una JA, Velasco G, Santamaria I, Ferrando A, Lopez-Otin C. Prostate-specific membrane antigen in breast carcinoma. Lancet 1997:349:1601.
8. Mannello F, Condemi L, Cardinal! A, Bianchi G, Gazzanelli G. High concentrations of prostate-specific antigen in urine of
9. women receiving oral contraceptives. Clin Chem 1998;44:181-3.
10. Ranganath LR, Lewis GA, Nobbs BT, Goddard PF, Ranfedera DC. Elevated serum prostate-specific antigen and pancreatic carcinoma. Postgrad Med J 1996;72:363-4.
11. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg 1993;128:586-90.
12. ' Kuopio T, Ekfors TO, Nikkanen V, Nevalanen TJ. Acinar cell carcinoma of the pancreas. Report of three cases. APMIS 1995:103:69-78.
13. Yu H, Diamandis EP. Measurement of serum prostate specific antigen levels in females and in prostatectomised males with an ultrasensitive immunoassay technique. J Urol 1994;153:1004-8.
14. Greenway BA. Effect of flutamide on survival in patients with pancreatic cancer: results of a prospective, randomised, double blind, placebo controlled trial. Br Med J 1998;316:1935-8.
15. Sharma JJ, Razvillas B, Stephens CD, Hilsenbeck SG, Sharma A, Rothenberg ML. Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer. Invest New Drugs 1997;15:361-4.
16. Diamandis EP. New diagnostic applications of prostate-specific antigen. Br J Urol 1997;79(Suppl 1):87-91.
17. Watt KWK, Lee PJ, M'Timkulu, Chan WP, Loor R. Human prostate specific antigen: structural and functional similarity with serine protease. Proc Natl Acad Sci USA 1986;83:3166-70.
18. Uegaki K, Nio Y, Inoue Y, Minari Y, Sato Y, Song MM, et al. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer. Anticanc Res 1997;17:3841-7.
19. Wagner M, Cao T, Lopez ME, Hope C, van Nostrand K, Kobrin MS, et al. Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. Int J Cancer 1996;68:782-7.
20. Funatomi H, Itakura J, Ishiwata T, Pastan I, Thompson SA, Johnson GR, et al. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy. Int J Cancer 1997;72:512-7.
21. Kobari M, Kullenberg B, Bjorkman A, Matsuno S, Ihse I, Axelson J. The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptor for EGF and IGF 1. Int J Pancreatol 1998;24:85-95.
22. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate specific antigen (PSA) in an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocr Metab 1992;75:1046-53.
23. Korc M. Role of growth factors in pancreatic cancer. Surg Oncol ClinNAml998;7:25-41.
24. Friess H, Berberat P, Shilling M, Kunz J, Korc M, Buchler MW. Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J Mol Med 1996;74:35-42.
25. Killian CS, Corral DA, Kawinski E, Costantine RI. Mitogenic response of osteoblast cells to prostate specific antigen suggests an activation of latent TGF- and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 1993:192:940-7.